180 Life Sciences Corp. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
180 Life Sciences Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2016 to Q3 2024.
  • 180 Life Sciences Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 981K shares, a 134% increase year-over-year.
  • 180 Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 4.22M shares, a 71.6% decline from 2018.
  • 180 Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 14.9M shares, a 57.7% increase from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 981K +562K +134% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 919K +644K +234% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 638K +441K +224% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q3 2023 419K -1.54M -78.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 275K -1.43M -83.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 197K -1.51M -88.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 1.96M -31.8M -94.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.71M -29.8M -94.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 1.7M -26.2M -93.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 33.7M +16.9M +100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 31.5M +14.1M +81.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 28M +23.5M +527% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 16.9M +12.6M +295% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 17.4M +13.1M +311% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 4.46M -8.94M -66.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-22
Q4 2019 4.22M -10.7M -71.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-07
Q3 2019 4.26M -10.6M -71.3% Jul 1, 2019 Sep 30, 2019 10-Q/A 2021-02-05
Q2 2019 4.23M -10.7M -71.6% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-02-05
Q1 2019 13.4M -1.48M -9.96% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 14.9M +5.44M +57.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-07
Q3 2018 14.9M 0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 14.9M +9.59M +181% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 14.9M +12.4M +495% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 9.44M +6.94M +277% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 14.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 5.29M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 2.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 2.5M Sep 7, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.